BIAXIN Drug Patent Profile
✉ Email this page to a colleague
When do Biaxin patents expire, and what generic alternatives are available?
Biaxin is a drug marketed by Abbvie and is included in three NDAs.
The generic ingredient in BIAXIN is clarithromycin. There are twenty-one drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the clarithromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Biaxin
A generic version of BIAXIN was approved as clarithromycin by ACTAVIS LABS FL INC on June 24th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BIAXIN?
- What are the global sales for BIAXIN?
- What is Average Wholesale Price for BIAXIN?
Summary for BIAXIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Clinical Trials: | 48 |
| What excipients (inactive ingredients) are in BIAXIN? | BIAXIN excipients list |
| DailyMed Link: | BIAXIN at DailyMed |
Recent Clinical Trials for BIAXIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Emory University | Phase 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
| Nicolaas Bohnen, MD, PhD | Phase 1/Phase 2 |
US Patents and Regulatory Information for BIAXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | BIAXIN | clarithromycin | FOR SUSPENSION;ORAL | 050698-001 | Dec 23, 1993 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | BIAXIN | clarithromycin | TABLET;ORAL | 050662-001 | Oct 31, 1991 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | BIAXIN | clarithromycin | FOR SUSPENSION;ORAL | 050698-003 | Sep 30, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | BIAXIN | clarithromycin | FOR SUSPENSION;ORAL | 050698-002 | Dec 23, 1993 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | BIAXIN XL | clarithromycin | TABLET, EXTENDED RELEASE;ORAL | 050775-001 | Mar 3, 2000 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
